抗病毒免疫研究

A· S·
远东呼吸生理与病理科学中心哈巴罗夫斯克分院妇幼保护研究所

摘要

本文从分子细胞水平讨论抗病毒免疫的形成原理。抗病毒免疫通过细胞间相互作用（白细胞介素）受体和细胞 间相互作用（白细胞介素）对感染过程的活动形成适当的反应。本文介绍了抗病毒免疫形成的核心细胞机制，主要与病毒的 细胞内作用有关，这是由特异性细胞毒性 T 淋巴细胞、T 效应子和巨噬细胞的功能活性所保证的。详细讨论了体液抗病毒免疫 应答机制的主要阶段和细胞外病毒离子抗体的参与形式。考虑到病毒感染病原体的变化，分析人类抵抗力和适应性免疫复合 物的作用，我们应该更好地了解病毒与人体相互作用的方式、免疫系统抵御病毒攻击的特点以及抗病毒免疫的形成。

关键词

抗病毒免疫；体液和细胞免疫反应；非特异性耐药因素；免疫细胞；白细胞介素

参考

[1] Vorob'ev A.A., Bykov A.S., editors. Atlas of Medical Microbiology, Virology and Immunology. Moscow: Meditsinskoe informatsionnoe agentstvo; 2003 (in russian). [2] Belotskiy S.M., Avtalion R.R. Inflammation. Mobilization of cells and clinical effects. Moscow: BINOM; 2008 (in russian). [3] Donina S. A., Naykhin A.N., Petukhova G.D., Barantseva I.B., Chirkova T.V., Grigor'eva E.P., Rekstin A.R., Rudenko L.G. Meditsinskaya immunologiya 2006; 8(1):31-36. [4] Zheleznikova G.F. Meditsinskaya immunologiya 2006; 8(5-6):597-614. [5] Zaretskaya Yu.M., Lednev Yu.A. Gematologiya i transfuziologiya 2008; 1:28-32. [6] Ketlinskiy S. A. Meditsinskaya immunologiya 2012; 14(3):183-188. [7] Kozlov V.A., Borisov A.G., Smirnova S.V., Savchenko A.A. Practical aspects of diagnosis and treatment of immune disorders: a guide for physicians. Novosibirsk: Nauka; 2009 (in russian). [8] Lutsenko M.T., Solov'eva A.S. Fundamental'nye issledovaniya 2010; 2:68-74. [9] Seliverstova M.S., Lebedeva O.P., Tarasova T.K. Fundamental'nye issledovaniya 2013; 12:542-545. [10] Solov'eva A.S., Lutsenko M.T. Dal'nevostochnyy meditsinskiy zhurnal 2009; 2:42-44. [11] Behnen M., Leschczyk C., Möller S., Batel T., Klinger M., Solbach W., Laskay T. Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcγRIIIB and Mac-1. J. Immunol. 2014; 193(4):1954-1965. [12] Ellermann-Eriksen S. Macrophages and cytokines in the early defence against herpes simplex virus. Virol. J.2005; 3(2):59-89. [13] Horner H., Frank C., Dechant C., Repp R., Glennie M., Herrmann M., Stockmeyer B. Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity. J. Immunol. 2007; 179(1):337-345. [14] Jenkins M.K., Khoruts A., Ingulli E., Mueller D.L, McSorley S.J., Reinhardt R. L., Itano A., Pape K.A. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 2001; 19:23-45. [15] Lecocq M., Detry B., Guisset A., Pilette C. FcαRIMediated Inhibition of IL-12 Production and Priming by IFN-γ of Human Monocytes and Dendritic Cells. J. Immunol. 2013; 190(5):2362-2371. [16] Melchjorsen J., Sirén J., Julkunen I., Paludan S.R., Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J. Gen. Virol. 2006; 87(Pt.5):1099-1108. [17] Spaeny-Dekking E.H.A., Hanna W.L., Wolbink A.M., Wever P.C., Kummer A.J., Swaak A.J.G., Middeldorp J.M., Huisman H.G.,Froelich C.J., Hack C.E. Extra- cellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 1998; 160(7):3610-3616. [18] Smyth L.A., Hervouet C., Hayday T., Becker P.D., Ellis R., Lechler R.I., Lombardi G., Klavinskis L.S. Acquisition of MHC: peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo. J. Immunol. 2012; 189(5):2274-2282. [19] Uto T., Wang X., Sato K., Haraguchi M., Akagi T., Akashi M., Baba M. Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigenspecific humoral and cellular immunity. J. Immunol. 2007; 178(5):2979-2986. [20] Weidt G., Utermöhlen O., Zerrahn J., Reimann J., Deppert W., Lehmann-Grube F. CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 1994; 153(6):2554-2561. [21] Wensink A.C., Hack C.E., Bovenschen N. Granzymes regulate proinflammatory cytokine responses. J. Immunol. 2015; 194(2):491-497.